An Auckland regional audit of the nurse-led rheumatic fever secondary prophylaxis programme

New Zealand Medical Journal

Volumn 119, Issue 1243, 2006, Pages

  Grayson, Sarah ^a   Horsburgh, Margaret ^b   Lennon, Diana ^c  

^a STARSHIP CHILDREN S HOSPITAL   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BENZATHINE PENICILLIN;

ARTICLE; CHRONIC DISEASE; COMMUNITY CARE; COMMUNITY HEALTH NURSING; COST EFFECTIVENESS ANALYSIS; DISEASE CONTROL; HEALTH CARE DELIVERY; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MEDICAL AUDIT; NEW ZEALAND; NURSE PRACTITIONER; PATIENT COMPLIANCE; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; SECONDARY PREVENTION; WORLD HEALTH ORGANIZATION; CHILD; COST BENEFIT ANALYSIS; ECONOMICS; EVALUATION; INFECTION CONTROL; NURSING; NURSING EVALUATION RESEARCH; REGISTER; STANDARD; STATISTICS;

CHILD; COMMUNICABLE DISEASE CONTROL; COMMUNITY HEALTH NURSING; COST-BENEFIT ANALYSIS; HUMANS; MEDICAL AUDIT; NEW ZEALAND; NURSING EVALUATION RESEARCH; PATIENT COMPLIANCE; REGISTRIES; RHEUMATIC FEVER;

EID: 33750248073     PISSN: 11758716     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Lennon D. Acute rheumatic fever. In: Textbook of Paediatric Infectious Diseases 5th edition. Feigin RD & Cherry JD (eds). Baltimore: Saunders; 2004:413-26.
2. Anonymous. Community control of rheumatic heart disease in developing countries (2): strategies for prevention and control. WHO Chronicle. 1980:34:389-95.
3. Manyemba J, Mayosi BM. Penicillin for secondary prevention of rheumatic fever. Cochrane Database Syst Rev. 2002;(3):CD002227.
4. Newman JE, Lennon DR, Wong-Toi W. Patients with rheumatic fever recurrences. N Z Med J. 1984;97:678-80.
5. Lennon D. Proceedings of the XIV Lancet held Internat. Symposium on Streptococci & Streptococcal Diseases. ESR. 2000;503-12.
6. Frankish JD. Rheumatic fever prophylaxis: The Gisborne experience. N Z Med J. 1984;97:675-5.
7. Wood HF, Feinstein AR, Taranta A, et al. Long term epidemiologic study of subsequent prophylaxis, streptococcal infections and clinical sequalae, 111, comparative effectiveness of three prophylaxis regimens in preventing streptococcal infections and rheumatic recurrences. Annals of Internal Medicine. 1964:60(2 part 11, suppl.5):31-47.
8. Lennon D, as member of Rheumatic Fever Working Party. Circular letter to Medical Practitioners, Department of Health (HP 2/87) Streptococcal pharyngitis: prevention of rheumatic fever.
9. Baker M, Chakraborty M. Rheumatic fever in New Zealand in the 1990s: Still cause for concern. New Zealand Public Health Report. 1996;3:17-19.
10. Spinetto H. The Auckland Rheumatic Fever Register 1993-1999: An Audit., [Master of Health Science thesis], University of Auckland, 2002.
11. Lue HC. Long-Term outcome of patients-with rheumatic fever receiving Benzathine Penicillin G prophylaxis every three weeks versus every four weeks. Journal of Pediatrics. 1994; 125(5 Part 1):812-17.
12. Kaplan E. Public health implications of group A streptococcal infections in the 1990s. Pediatric Infectious Diseases Journal. 1994; 13(6):580-3.
13. Strasser T. Cost effective control of rheumatic fever in the community. Health Policy. 1985;5:159-64.
14. Kumar R. Compliance of secondary prophylaxis for controlling rheumatic fever and rheumatic heart disease in a rural area of Northern India. Indian Heart Journal. 1997;49:282-8.
15. Bach JF. 10-year educational programme aimed at rheumatic fever in two French Caribbean islands. Lancet. 1996;347:644-8.
16. Walker K. The problem of compliance in rheumatic fever. South African Medical Journal. 1987;72:781-3.
17. Rolston DDK. Patient compliance with prophylactic benzathine penicillin for rheumatic fever. Med J Aust. 1981;2:160-1.